Edward Andrle's most recent trade in NeuroOne Medical Technologies Corp was a trade of 50,000 Option to Purchase Common Stock done . Disclosure was reported to the exchange on June 23, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
NeuroOne Medical Technolog... | Edward Andrle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 50,000 | 50,000 | - | - | Option to Purchase Common Stock | |
NeuroOne Medical Technolog... | Edward Andrle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 27,778 | 92,003 | - | 0 | Common Stock | |
NeuroOne Medical Technolog... | Edward Andrle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 17,025 | 17,025 | - | - | Option to Purchase Common Stock | |
NeuroOne Medical Technolog... | Edward Andrle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 20,576 | 64,225 | - | 0 | Common Stock | |
NeuroOne Medical Technolog... | Edward Andrle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 18,927 | 18,927 | - | - | Option to Purchase Common Stock | |
NeuroOne Medical Technolog... | Edward Andrle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 29,240 | 43,649 | - | 0 | Common Stock | |
NeuroOne Medical Technolog... | Edward Andrle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 29,230 | 29,230 | - | - | Option to Purchase Common Stock | |
NeuroOne Medical Technolog... | Edward Andrle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 4,682 | 4,682 | - | - | Option to Purchase Common Stock | |
NeuroOne Medical Technolog... | Edward Andrle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 4,592 | 14,404 | - | 0 | Common Stock |